Pediatric Physicians Should Revisit Approaches to Marijuana

Share this content:
Pediatric Physicians Should Revisit Approaches to Marijuana
Pediatric Physicians Should Revisit Approaches to Marijuana

TUESDAY, Oct. 10, 2017 (HealthDay News) -- In light of the changing legal status of marijuana, physicians should provide counseling on its effects to adolescents, according to an opinion article published online Oct. 9 in JAMA Pediatrics.

Jonathan Reiss, M.D., from the University of California in San Diego, and colleagues discussed the implications of legalizing marijuana, specifically the impact on minors.

The researchers note that supporters of legalization argue that it will lead to increased regulatory capacity, which will allow restriction of marijuana's sale to minors; however, critics raise concerns that legalization will promote a more permissive attitude toward marijuana use among minors, possibly leading to increased rates of use. In the changing legal environment, pediatric physicians must review their approach to screening for marijuana use and discussing the associated health consequences. Physicians should consider screening all adolescents and young adults for marijuana use at preventive care visits; validated tools can be used to determine the severity and patterns of use. Parents of young children should also be screened for marijuana use and to ascertain how marijuana products are stored in the home. Physicians should provide comprehensive counseling on the impact of marijuana use, focusing on the short- and long-term neurocognitive risks of marijuana exposure on the developing brain.

"Improved screening tactics, thoughtful anticipatory guidance around marijuana use, and increased community advocacy may enable physicians to protect young people from harm in our changing legal environment," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »